Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027273
Filing Date
2024-11-19
Accepted
2024-11-19 19:18:39
Documents
1
Period of Report
2024-11-17

Document Format Files

Seq Description Document Type Size
1 form4-11202024_121135.html 4  
1 form4-11202024_121135.xml 4 13244
  Complete submission text file 0001415889-24-027273.txt   15017
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

EIN.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139
Business Address
Yea Christopher (Reporting) CIK: 0001691102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 241477831